Postherpetic Neuralgia Study

Study Purpose: To investigate the efficacy & tolerability of an FDA approved medication in patients with Postherpetic Neuralgia.

Basic Eligibility Criteria:

• Patients 18 years and older
• Diagnosed with Postherpetic neuralgia

If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:

Kayla Kennedy, Clinical Research Administrative Assistant, at kkennedy@anscneuro.com 

or any of our Clinical Research Coordinators: 

Grace Castaneda at gcastaneda@anscneuro.com 

Cindy Chu at cchu@anscneuro.com or

Alicia Castelot at acastelot@anscneuro.com or

Lisa Lazarecki at llazarecki@anscneuro.com or

Debra D’Angelo at ddangelo@anscneuro.com or

You may also call 203.333.1151 and we will be happy to answer any of your questions.